Evidence map›Paper›PMID 29151129›Full record

ArticleRheumatology international2018

One novel and two uncommon MEFV mutations in Japanese patients with familial Mediterranean fever: a clinicogenetic study.

Dai Kishida, Masahide Yazaki, Akinori Nakamura, Fumio Nomura, Takeshi Kondo, Takanori Uehara, Masatomi Ikusaka, Akira Ohya, Norihiko Watanabe, Ryuta Endo and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Dai KishidaDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. dkishida@shinshu-u.ac.jp.ORCID http://orcid.org/0000-0001-8309-7984
Masahide YazakiInstitute for Biomedical Sciences, Shinshu University, Matsumoto, Japan.
Akinori NakamuraDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Fumio NomuraDivision of Clinical Genetics, Chiba University Hospital, Chiba, Japan.
Takeshi KondoDepartment of General Medicine, Chiba University Hospital, Chiba, Japan.
Takanori UeharaDepartment of General Medicine, Chiba University Hospital, Chiba, Japan.
Masatomi IkusakaDepartment of General Medicine, Chiba University Hospital, Chiba, Japan.
Akira OhyaDepartment of Emergency General Medicine, Mimihara General Hospital, Osaka, Japan.
Norihiko WatanabeDepartment of Rheumatology and Clinical Immunology, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Ryuta EndoDepartment of Rheumatology and Clinical Immunology, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Satoshi KawaaiDepartment of Rheumatology and Clinical Immunology, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Yasuhiro ShimojimaDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Yoshiki SekijimaDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Shinshu University · JPChiba University Hospital · JPChibaken Saiseikai Narashino Hospital · JPOsaka City General Hospital · JP

Funding

JSPS KAKENHI JP17K15892JSPS KAKENHI JP26860447
6 · The paper itself

Abstract

Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by mutations in the MEFV gene and characterized by recurrent episodes of fever and polyserositis. To date, over 317 MEFV mutations have been reported, only nine of which account for almost all Japanese patients with FMF. Therefore, the prevalence of rare MEFV variants and their clinical characteristics remains unclear. This study identified MEFV mutations previously unreported in the Japanese population and described their clinical features. We performed MEFV genetic testing in 488 Japanese patients with clinically suspected FMF. Of these patients, we retrospectively analyzed three patients with novel or very uncommon MEFV mutations. In all patients, the clinical diagnosis of FMF was made according to Tel-Hashomer's criteria. One novel missense mutation (N679H) and two rare mutations (T681I and R410H) were identified in the MEFV gene. These mutations were found in compound heterozygous or complex genotypes with other known mutations in exons 1 or 2. According to clinical images, all three patients exhibited typical FMF symptoms. A number of patients with FMF caused by novel or uncommon MEFV variants might exist in the Japanese population; therefore, careful genetic testing is required for accurate diagnosis of this curable genetic disorder.

Indexed as

MutationAdultDNA Mutational AnalysisFamilial Mediterranean FeverFemaleGene FrequencyGenotypeHumansJapanMiddle AgedPyrinPyrinExon 10Familial Mediterranean feverMEFVN679HRare mutations

Identifiers

PMID29151129
OpenAlexW2770387726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.